Cargando…
新型免疫肿瘤治疗临床研究现状及应用前景
Recently, immune-oncologic therapy advanced rapidly and has been defined as another option, following surgery, radiotherapy, chemotherapy and molecular targeted therapy, for treatment of malignant diseases. To date, several immune checkpoint inhibitors and compounds have been approved to treat vario...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973373/ https://www.ncbi.nlm.nih.gov/pubmed/28935020 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.09.10 |
| _version_ | 1783326613494038528 |
|---|---|
| collection | PubMed |
| description | Recently, immune-oncologic therapy advanced rapidly and has been defined as another option, following surgery, radiotherapy, chemotherapy and molecular targeted therapy, for treatment of malignant diseases. To date, several immune checkpoint inhibitors and compounds have been approved to treat various of malignant diseases with efficiency. Meanwhile, more and more potential therapeutic targets in processes of the cancer immunity have been noticed. We aimed to summarize the research status and clinical prospects of novel immune-oncologic treatment agencies targeted to different steps of the cancer-immunity cycle. |
| format | Online Article Text |
| id | pubmed-5973373 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59733732018-07-06 新型免疫肿瘤治疗临床研究现状及应用前景 Zhongguo Fei Ai Za Zhi 综述 Recently, immune-oncologic therapy advanced rapidly and has been defined as another option, following surgery, radiotherapy, chemotherapy and molecular targeted therapy, for treatment of malignant diseases. To date, several immune checkpoint inhibitors and compounds have been approved to treat various of malignant diseases with efficiency. Meanwhile, more and more potential therapeutic targets in processes of the cancer immunity have been noticed. We aimed to summarize the research status and clinical prospects of novel immune-oncologic treatment agencies targeted to different steps of the cancer-immunity cycle. 中国肺癌杂志编辑部 2017-09-20 /pmc/articles/PMC5973373/ /pubmed/28935020 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.09.10 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
| spellingShingle | 综述 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title_full | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title_fullStr | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title_full_unstemmed | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title_short | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| title_sort | 新型免疫肿瘤治疗临床研究现状及应用前景 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973373/ https://www.ncbi.nlm.nih.gov/pubmed/28935020 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.09.10 |
| work_keys_str_mv | AT xīnxíngmiǎnyìzhǒngliúzhìliáolínchuángyánjiūxiànzhuàngjíyīngyòngqiánjǐng AT xīnxíngmiǎnyìzhǒngliúzhìliáolínchuángyánjiūxiànzhuàngjíyīngyòngqiánjǐng |